Citius Pharmaceuticals, Inc. Stock-Based Compensation
Citius Pharmaceuticals, Inc. (CTXR) reported Stock-Based Compensation of $3.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.81M, a 40.11% increase year-over-year.
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.79M, a 40.20% increase year-over-year.
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.28M, a 69.53% increase year-over-year.
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.89M, a 9.41% increase year-over-year.
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $10.84M, a 8.47% decline from fiscal 2024.
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $11.84M, a 78.94% increase from fiscal 2023.
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $6.62M, a 69.40% increase from fiscal 2022.
- Citius Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $3.91M, a 168.45% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.81M 10-Q · filed 2026-08-14 | $7.60M derived: sum of 2 quarters · filed 2026-08-14 | $11.88M 10-Q · filed 2026-08-14 | $14.77M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $3.79M 10-Q · filed 2026-05-15 | $8.07M 10-Q · filed 2026-05-15 | $10.96M derived: sum of 3 quarters · filed 2026-05-15 | $13.68M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $4.28M 10-Q · filed 2026-02-13 | $7.17M derived: sum of 2 quarters · filed 2026-02-13 | $9.89M derived: sum of 3 quarters · filed 2026-08-14 | $12.59M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-09-30 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $5.61M derived: sum of 2 quarters · filed 2026-08-14 | $8.31M derived: sum of 3 quarters · filed 2026-08-14 | $10.84M 10-K · filed 2025-12-23 | |
| 2025-06-30 | $2.72M 10-Q · filed 2026-08-14 | $5.42M derived: sum of 2 quarters · filed 2026-08-14 | $7.95M 10-Q · filed 2026-08-14 | $10.59M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $2.70M 10-Q · filed 2026-05-15 | $5.23M 10-Q · filed 2026-05-15 | $7.87M derived: sum of 3 quarters · filed 2026-05-15 | $10.93M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $2.52M 10-Q · filed 2026-02-13 | $5.17M derived: sum of 2 quarters · filed 2026-02-13 | $8.23M derived: sum of 3 quarters · filed 2026-02-13 | $11.31M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $5.70M derived: sum of 2 quarters · filed 2025-12-23 | $8.78M derived: sum of 3 quarters · filed 2025-12-23 | $11.84M 10-K · filed 2025-12-23 | |
| 2024-06-30 | $3.06M 10-Q · filed 2025-08-12 | $6.14M derived: sum of 2 quarters · filed 2025-08-12 | $9.20M 10-Q · filed 2025-08-12 | $12.27M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $3.08M 10-Q · filed 2025-05-14 | $6.14M 10-Q · filed 2025-05-14 | $9.21M derived: sum of 3 quarters · filed 2025-05-14 | $10.39M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $3.06M 10-Q · filed 2025-02-14 | $6.13M derived: sum of 2 quarters · filed 2025-02-14 | $7.31M derived: sum of 3 quarters · filed 2025-02-14 | $8.47M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | $4.25M derived: sum of 2 quarters · filed 2024-12-27 | $5.42M derived: sum of 3 quarters · filed 2024-12-27 | $6.62M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $1.17M 10-Q · filed 2024-08-12 | $2.34M derived: sum of 2 quarters · filed 2024-08-12 | $3.54M 10-Q · filed 2024-08-12 | $4.52M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $1.17M 10-Q · filed 2024-05-14 | $2.37M 10-Q · filed 2024-05-14 | $3.34M derived: sum of 3 quarters · filed 2024-05-14 | $4.35M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $1.20M 10-Q · filed 2024-02-14 | $2.18M derived: sum of 2 quarters · filed 2024-02-14 | $3.18M derived: sum of 3 quarters · filed 2024-02-14 | $4.20M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $976.67K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | $1.98M derived: sum of 2 quarters · filed 2023-12-29 | $3.00M derived: sum of 3 quarters · filed 2023-12-29 | $3.91M 10-K · filed 2023-12-29 | |
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-14 | $2.02M derived: sum of 2 quarters · filed 2023-08-14 | $2.93M 10-Q · filed 2023-08-14 | $3.39M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $1.02M 10-Q · filed 2023-05-12 | $1.93M 10-Q · filed 2023-05-12 | $2.39M derived: sum of 3 quarters · filed 2023-05-12 | $2.76M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $904.60K 10-Q · filed 2023-02-10 | $1.37M derived: sum of 2 quarters · filed 2023-02-10 | $1.74M derived: sum of 3 quarters · filed 2023-02-10 | $2.08M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-09-30 | $461.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $835.43K derived: sum of 2 quarters · filed 2022-12-22 | $1.18M derived: sum of 3 quarters · filed 2022-12-22 | $1.45M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $373.57K 10-Q · filed 2022-08-11 | $716.53K derived: sum of 2 quarters · filed 2022-08-11 | $993.11K 10-Q · filed 2022-08-11 | $1.24M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $342.96K 10-Q · filed 2022-05-12 | $619.54K 10-Q · filed 2022-05-12 | $868.58K derived: sum of 3 quarters · filed 2022-05-12 | $1.04M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $276.58K 10-Q · filed 2022-02-10 | $525.62K derived: sum of 2 quarters · filed 2022-02-10 | $700.63K derived: sum of 3 quarters · filed 2022-02-10 | $859.46K derived: sum of 4 quarters · filed 2022-02-10 | |
| 2020-09-30 | $249.03K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $424.04K derived: sum of 2 quarters · filed 2021-12-15 | $582.88K derived: sum of 3 quarters · filed 2021-12-15 | $803.26K 10-K · filed 2021-12-15 | |
| 2020-06-30 | $175.01K 10-Q · filed 2021-08-12 | $333.84K derived: sum of 2 quarters · filed 2021-08-12 | $554.23K 10-Q · filed 2021-08-12 | $691.26K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $158.83K 10-Q · filed 2021-05-13 | $379.22K 10-Q · filed 2021-05-13 | $516.25K derived: sum of 3 quarters · filed 2021-05-13 | $720.26K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $220.38K 10-Q · filed 2021-02-11 | $357.42K derived: sum of 2 quarters · filed 2021-02-11 | $561.42K derived: sum of 3 quarters · filed 2021-02-11 | $765.12K derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-09-30 | $137.04K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | $341.04K derived: sum of 2 quarters · filed 2020-12-16 | $544.73K derived: sum of 3 quarters · filed 2020-12-16 | $715.98K 10-K · filed 2020-12-16 | |
| 2019-06-30 | $204.00K 10-Q · filed 2020-08-14 | $407.70K derived: sum of 2 quarters · filed 2020-08-14 | $578.95K 10-Q · filed 2020-08-14 | $729.56K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $203.69K 10-Q · filed 2020-05-14 | $374.94K 10-Q · filed 2020-05-14 | $525.56K derived: sum of 3 quarters · filed 2020-05-14 | $649.96K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $171.25K 10-Q · filed 2020-02-13 | $321.87K derived: sum of 2 quarters · filed 2020-02-13 | $446.26K derived: sum of 3 quarters · filed 2020-02-13 | $660.93K derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-09-30 | $150.62K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $275.01K derived: sum of 2 quarters · filed 2019-12-16 | $489.68K derived: sum of 3 quarters · filed 2019-12-16 | $779.70K 10-K · filed 2019-12-16 | |
| 2018-06-30 | $124.40K 10-Q · filed 2018-08-14 | $339.06K derived: sum of 2 quarters · filed 2019-08-14 | $629.09K 10-Q · filed 2019-08-14 | $807.35K derived: sum of 4 quarters · filed 2019-12-16 | |
| 2018-03-31 | $214.67K 10-Q · filed 2019-05-15 | $504.69K 10-Q · filed 2019-05-15 | $682.95K derived: sum of 3 quarters · filed 2019-12-16 | $949.76K derived: sum of 4 quarters · filed 2019-12-16 | |
| 2017-12-31 | $290.02K 10-Q · filed 2019-02-14 | $468.29K derived: sum of 2 quarters · filed 2019-12-16 | $735.10K derived: sum of 3 quarters · filed 2019-12-16 | $1.04M derived: sum of 4 quarters · filed 2019-12-16 | |
| 2017-09-30 | $178.26K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $445.08K derived: sum of 2 quarters · filed 2019-12-16 | $745.11K derived: sum of 3 quarters · filed 2019-12-16 | $986.62K 10-K · filed 2019-12-16 | |
| 2017-06-30 | $266.81K 10-Q · filed 2018-08-14 | $566.84K derived: sum of 2 quarters · filed 2018-08-14 | $808.36K 10-Q · filed 2018-08-14 | $1.02M derived: sum of 4 quarters · filed 2018-12-11 | |
| 2017-03-31 | $300.03K 10-Q · filed 2018-05-11 | $541.54K 10-Q · filed 2018-05-11 | $758.02K derived: sum of 3 quarters · filed 2018-12-11 | $1.04M derived: sum of 4 quarters · filed 2018-12-11 | |
| 2016-12-31 | $241.51K 10-Q · filed 2018-02-14 | $457.99K derived: sum of 2 quarters · filed 2018-12-11 | $738.75K derived: sum of 3 quarters · filed 2018-12-11 | $854.37K derived: sum of 4 quarters · filed 2018-12-11 | |
| 2016-09-30 | $216.47K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $497.24K derived: sum of 2 quarters · filed 2018-12-11 | $612.85K derived: sum of 3 quarters · filed 2018-12-11 | $732.15K 10-K · filed 2018-12-11 | |
| 2016-06-30 | $280.76K 10-Q · filed 2017-08-14 | $396.38K derived: sum of 2 quarters · filed 2017-08-14 | $515.68K 10-Q · filed 2017-08-14 | $517.68K 10-Q · filed 2016-08-15 | $622.87K derived: sum of 4 quarters · filed 2017-12-13 |
| 2016-03-31 | $115.61K 10-Q · filed 2017-05-15 | $236.91K 10-Q · filed 2017-05-15 | $342.11K derived: sum of 3 quarters · filed 2017-12-13 | $505.65K derived: sum of 4 quarters · filed 2017-12-13 | |
| 2015-12-31 | $121.30K 10-Q · filed 2017-02-14 | $226.49K derived: sum of 2 quarters · filed 2017-12-13 | $390.04K derived: sum of 3 quarters · filed 2017-12-13 | $498.81K derived: sum of 4 quarters · filed 2017-12-13 | |
| 2015-09-30 | $105.19K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-13 | $268.74K derived: sum of 2 quarters · filed 2017-12-13 | $377.51K derived: sum of 3 quarters · filed 2017-12-13 | $486.27K 10-K · filed 2017-12-13 | |
| 2015-06-30 | $163.55K 10-Q · filed 2016-08-15 | $272.31K derived: sum of 2 quarters · filed 2016-08-15 | $381.08K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $108.77K 10-Q · filed 2016-05-20 | $217.53K 10-Q · filed 2016-05-20 | |||
| 2014-12-31 | $108.76K 10-Q · filed 2016-02-12 | ||||
| 2014-09-30 | $470.19K 10-K · filed 2016-12-23 | $470.19K 10-K · filed 2016-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |